BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12810691)

  • 21. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
    Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
    Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caspase activation inhibits proteasome function during apoptosis.
    Sun XM; Butterworth M; MacFarlane M; Dubiel W; Ciechanover A; Cohen GM
    Mol Cell; 2004 Apr; 14(1):81-93. PubMed ID: 15068805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells.
    Kuusisto E; Suuronen T; Salminen A
    Biochem Biophys Res Commun; 2001 Jan; 280(1):223-8. PubMed ID: 11162503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
    Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth JA; Tschopp J; Tanaka N
    Oncogene; 2001 Aug; 20(37):5225-31. PubMed ID: 11526513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tripeptidyl-peptidase II: a multi-purpose peptidase.
    Tomkinson B; Lindås AC
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1933-7. PubMed ID: 16125107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
    Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X
    Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
    Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
    Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.
    Griffith TS; Kucaba TA; O'Donnell MA; Burns J; Benetatos C; McKinlay MA; Condon S; Chunduru S
    Apoptosis; 2011 Jan; 16(1):13-26. PubMed ID: 20734142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
    Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammalian mitochondrial IAP binding proteins.
    Vaux DL; Silke J
    Biochem Biophys Res Commun; 2003 May; 304(3):499-504. PubMed ID: 12729584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there an alternative to the proteasome in cytosolic protein degradation?
    Antón LC; Villasevil EM
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):839-42. PubMed ID: 18793147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Smac/DIABLO in mouse preimplantation embryos and its correlation to apoptosis and fragmentation.
    Honda Y; Tanikawa H; Fukuda J; Kawamura K; Sato N; Sato T; Shimizu Y; Kodama H; Tanaka T
    Mol Hum Reprod; 2005 Mar; 11(3):183-8. PubMed ID: 15709158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical modeling of the regulation of caspase-3 activation and degradation.
    Stucki JW; Simon HU
    J Theor Biol; 2005 May; 234(1):123-31. PubMed ID: 15721041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A proteolytic system that compensates for loss of proteasome function.
    Glas R; Bogyo M; McMaster JS; Gaczynska M; Ploegh HL
    Nature; 1998 Apr; 392(6676):618-22. PubMed ID: 9560160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smac mimetics as new cancer therapeutics.
    Chen DJ; Huerta S
    Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein.
    Hegde R; Srinivasula SM; Datta P; Madesh M; Wassell R; Zhang Z; Cheong N; Nejmeh J; Fernandes-Alnemri T; Hoshino S; Alnemri ES
    J Biol Chem; 2003 Oct; 278(40):38699-706. PubMed ID: 12865429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectopic expression of new alternative splice variant of Smac/DIABLO increases mammospheres formation.
    Martinez-Ruiz GU; Victoria-Acosta G; Vazquez-Santillan KI; Jimenez-Hernandez L; Muñoz-Galindo L; Ceballos-Cancino G; Maldonado V; Melendez-Zajgla J
    Int J Clin Exp Pathol; 2014; 7(9):5515-26. PubMed ID: 25337193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An IAP-IAP complex inhibits apoptosis.
    Dohi T; Okada K; Xia F; Wilford CE; Samuel T; Welsh K; Marusawa H; Zou H; Armstrong R; Matsuzawa S; Salvesen GS; Reed JC; Altieri DC
    J Biol Chem; 2004 Aug; 279(33):34087-90. PubMed ID: 15218035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The changes in the activity of tripeptidyl peptidase II in experimental atherosclerosis and hypertension].
    Pashevin DO; Honcharov SV; Tumanovs'ka LV; Dosenko VIe; Moĭbenko OO
    Fiziol Zh (1994); 2014; 60(3):27-31. PubMed ID: 25095668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reaper is regulated by IAP-mediated ubiquitination.
    Olson MR; Holley CL; Yoo SJ; Huh JR; Hay BA; Kornbluth S
    J Biol Chem; 2003 Feb; 278(6):4028-34. PubMed ID: 12446669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.